Abstract
The administration of an ultra-short-acting β-adrenergic antagonist, esmolol, has been introduced as a novel method for beating-heart surgery. In the present study, a new ultra-short-acting β-blocker, ONO-1101, was administered during cardiopulmonary bypass (CPB) to investigate its effects on cardiac function and hemodynamics. Nine adult mongrel dogs underwent 60 min of CPB during which they were given either ONO-1101 (ONO group;n=4) or saline (control group;n=5). In the ONO group, the hearts became flaccid enough for surgery to be performed without cardiac standstill within 10min after the commencement of ONO-1101 with significant decreases in the heart rate, the preload recruitable stroke work (PRSW), and the slope of the endsystolic left ventricular pressure-volume relationship (Emax). The mean arterial pressure and systemic vascular resistance also decreased, but were maintained above 50 mmHg during CPB without catecholamine. These indices increased to the control group level 20 min after the discontinuation of ONO-1101. The serum concentration of ONO-1101 decreased from the maximum level of 121±15 μg/ml soon after infusion to 11 ±5 μg/ml within 30 min after discontinuation. These data suggest that ONO-1101 may be useful to enable beating-heart surgery to be performed without aortic cross-clamp as an ultra-short-acting β-adrenergic blocker.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abramson DC, Pivalizza EG, Gottschalk LI (1995) Drug management for coronary revascularization without cardiac standstill: the use of high dose esmolol. J Cardiothorac Vasc Anesth 9:184–188
Prik J, Kellovsky P (1995) An alternative to cardioplegia. Ann Thorac Surg 60:464–465
Sweeney MS, Frazier OH (1992) Device-supported myocardial revascularization: safe help for sick hearts. Ann Thorac Surg 54:1065–1070
Matsuda H, Fukushima N, Kadoba K, Sawa Y, Nomura F, Kume Y, Miyagawa S, Shimazaki Y (1996) Application of ultra-short acting beta-blockade (Esmolol) in pediatric open heart surgery: a trial in total anomalous pulmonary venous return. J Cardiac Surg 11:101–105
Pivalizza EG, Sweeney MS (1997) High-dose esmolol and cardiopulmonary bypass for mitral valve replacement in the beating heart. J Cardiothorac Vasc Anesth Jun 11(4):485–486
Waldenberger FR, Hotz H, Haisjackl M, Konertz W (1996) Surgical coronary revascularization of the beating heart. Z Kardiol 85 suppl 4:35–41
Olearchyk AS (1995) Calcified ascending aorta and coronary artery disease. Ann Thorac Surg 59:1013–1015
Takahashi T, Kadoba K, Taniguchi K, Sawa Y, Imagawa H, Masai T, Matsuda H (1996) Repair of postinfarction ventricular septal defect on a beating heart. Ann Thorac Surg 61:1816–1817
Muraki K, Nakagawa H, Nagano N, Henmi S, Kawasumi Y, Nakanishi T, Imaizumi K, Tokuno T, Atsuki K, Imaizumi Y, Watanabe M (1996) Effects of ono-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle. J Pharmacol Exp Ther 278(2):555–563
Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM (1983) Kinetics of esmolol, an ultra-short-acting beta-blocker, and of its major metabolite. Clin Pharmacol Ther 34:427–434
Iguchi S, Iwamura H, Nishizaki M, Hayashi A, Senokuchi K, Kobayashi K, Sakaki K, Hachiya K, Ichioka Y, Kawamura M (1992) Development of a highly Cardioselective ultra short-acting beta-blocker, ONO-1101. Chem Pharm Bull 40:1462–1469
Randall CC, Thomas HK, Birgit D, Steven B, James AD (1995) The effect of esmolol given during cardiopulmonary bypass. Anesth Analg 80:28–40
Flaherty JF, Wong B, La Follette G, Warnock DG, Hulse JD, Gambertoglio JG (1989) Pharmacokinetics of esmolol and ASL-8123 in renal failure. Clin Pharmacol Ther 45:312–317
Matsuwaka R, Matsuda H, Shirakura R, Kaneko M, Fukushima N, Taniguchi K, Nakano S, Kawashima Y (1994) Changes in left ventricular performance after global ischemia: Assessing LV pressure-volume relationship. Ann Thorac Surg 57:151–156
Abrams J, Allen J, Allin D, Anderson J, Anderson S, Blanski L, Chadda K, DiBianco R, Favrot L, Gonzalez J, Horowitz L, Laddu A, Lee R, MacCosbe P, Morganroth J, Narula O, Singh B, Singh J, Steck J, Swerdlow C, Turlapaty P, Waldo A (1985) Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial. Am Heart J 110:913–922
Benfield P, Sorkin EM (1987) Esmolol: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 33:397–421
Menkhans PG, Reves JG (1985) Cardiovascular effects of esmolol in anesthetized humans. Anesth Analg 64:327–334
Lonn U, Peterzen B, Granfeldt H, Casimir-Ahn H (1994) Coronary artery operation supported by the hemopump: an experimental study on pig. Ann Thorac Surg 58:516–518
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ahmet, I., Fukushima, N., Sawa, Y. et al. The effects of a new ultra-short-acting β-adrenergic blocker, ONO-1101, on cardiac function during and after cardiopulmonary bypass. Surg Today 29, 248–254 (1999). https://doi.org/10.1007/BF02483015
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02483015